Valuation: Divi's Laboratories Limited

Market Cap 2,39600Cr 2.51TCr 2.16TCr 2.02TCr 1.85TCr 3.49TCr 3.5TCr 24TCr 9.28TCr 1,20900Cr 9.43TCr 9.23TCr 4,00300Cr P/E 2027 *
73.7x
P/E 2028 * 61x
Enterprise Value 2,36100Cr 2.48TCr 2.12TCr 1.99TCr 1.82TCr 3.44TCr 3.45TCr 24TCr 9.15TCr 1,19100Cr 9.29TCr 9.09TCr 3,94500Cr EV / Sales 2027 *
18.8x
EV / Sales 2028 * 15.7x
Free-Float
48.01%
Yield 2027 *
0.39%
Yield 2028 * 0.43%
1 day+3.21%
1 week+5.43%
Current month+12.03%
1 month+21.73%
3 months+33.64%
6 months+39.40%
Current year+41.18%
1 week 8,457.5
Extreme 8457.5
9,043
1 month 7,220.5
Extreme 7220.5
9,043
Current year 5,647.5
Extreme 5647.5
9,043
1 year 5,636.5
Extreme 5636.5
9,043
3 years 3,295.3
Extreme 3295.3
9,043
5 years 2,730
Extreme 2730
9,043
10 years 532.65
Extreme 532.65
9,043
Manager TitleAgeSince
Chief Executive Officer 48 04/01/2020
Chief Executive Officer 75 26/11/2009
Director of Finance/CFO 65 01/08/2025
Director TitleAgeSince
Director/Board Member 48 26/11/2009
Chairman 75 26/11/2009
Director/Board Member 68 01/10/1994
Date Insider Type Main position Quantity % Market Cap.
26/03/25 Sell

Executive/Senior Manager

25,000 0.0094%
15/03/25 Sell 300 0.0001%
17/02/25 Sell 500 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
+3.21%+5.43%+45.79%+148.40% 2.43TCr
-3.59%-7.10%+61.60%+114.83% 1,10000Cr
-1.15%-1.25%+52.98%+62.41% 66TCr
-1.09%-1.15%+26.18%+79.22% 47TCr
-1.47%+0.24%+42.09%+42.09% 37TCr
-0.90%+0.05%+25.57%+41.75% 30TCr
-1.94%+1.53%+3.05%+13.24% 26TCr
-0.43%-0.46%+52.06%+71.75% 24TCr
-0.93%+1.84%-13.11%-52.28% 21TCr
-0.46%+0.33%+29.05%+92.67% 18TCr
Average -0.88%+0.34%+32.53%+61.41% 38.27TCr
Weighted average by Cap. -1.79%-1.56%+40.57%+68.75%

Financials

2027 *2028 *
Net sales 13TCr 131.75Cr 113.08Cr 106.14Cr 97Cr 182.95Cr 183.83Cr 1.26TCr 486.79Cr 6.34TCr 494.69Cr 483.95Cr 21TCr 15TCr 157.15Cr 134.88Cr 126.6Cr 115.63Cr 218.22Cr 219.27Cr 1.5TCr 580.63Cr 7.56TCr 590.06Cr 577.25Cr 25TCr
Net income 3.26TCr 34Cr 29Cr 28Cr 25Cr 47Cr 48Cr 325.55Cr 126.16Cr 1.64TCr 128.21Cr 125.43Cr 5.44TCr 3.94TCr 41Cr 35Cr 33Cr 30Cr 57Cr 58Cr 393.49Cr 152.49Cr 1.99TCr 154.97Cr 151.61Cr 6.58TCr
Net Debt -3.5TCr -37Cr -31Cr -30Cr -27Cr -51Cr -51Cr -349.84Cr -135.58Cr -1.77TCr -137.78Cr -134.79Cr -5.85TCr -4.49TCr -47Cr -40Cr -38Cr -35Cr -65Cr -66Cr -448.34Cr -173.75Cr -2.26TCr -176.57Cr -172.74Cr -7.49TCr
Logo Divi's Laboratories Limited
Divi's Laboratories Limited is specialized in the development and manufacture of active pharmaceutical ingredients, intermediates and nutraceutical ingredients. Net sales by source of revenue break down into product sales (97.9%) and service sales (2.1%). At the end of March 2020, the group has 2 production sites located in India.
Employees
11,565
Date Price Change Volume
26/26/26 ₹9,025.00 +3.21% 7,08,128
25/26/25 ₹8,744.50 +2.92% 5,63,721
24/26/24 ₹8,496.00 -1.17% 2,51,013
21/26/21 ₹8,597.00 +0.32% 1,80,697
20/26/20 ₹8,570.00 +0.12% 1,98,190
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
29
Last Close Price
9,025.00INR
Average target price
8,292.48INR
Spread / Average Target
-8.12%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DIVISLAB Stock